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We report that protease nexin-1 (PN-1), a serine protease inhibitor known to have neurite-promoting effects, is made by Schwann cells in tissue 
culture. Three modalities have been used to demonstrate the presence of PN-I in Schwann cell cultures. Immunostaining of the cultures with anti-PN-1 
antibody gives positive staining over cells and matrix. Western blots of Schwann cell conditioned medium (CM) using anti-PN-I antibody show 
a band that co-migrates with the PN-1 standard at 45 kDa. Biochemical assay for protease inhibitory activity shows that CM inhibits thrombin 
activity in a calorimetric assay. The CM-mediated inhibition of thrombin is reversed if the CM is pre-incubated with anti-PN-I antibody. 
It has been hypothesized that the balance between 
proteolytic and protease inhibitory activity plays an im- 
portant role in normal neuronal development and in the 
response of the nervous system to injury [16]. The pro- 
tease nexins are a group of serine protease inhibitors that 
were originally described in conditioned media from 
forskolin fibroblast cultures. They are classified by mole- 
cular weight and by the pattern of proteases they inhibit 
[10]. Protease nexin-1 (PN-I) is the best characterized of 
the nexins, and has been demonstrated in conditioned 
media from a variety of cell types [1], including astroglia 
[18]. PN-1 has been shown to be identical to the glial- 
derived neurite promoting factor (now re-named glia- 
derived nexin) that affects neuronal migration and neur- 
ite extension [5, 11]. Changes in PN-1 activity have been 
demonstrated in the normal developmental processes of 
the central nervous system (CNS) [21] and in the patho- 
logical processes associated with Alzheimer's disease 
[19]. In the peripheral nervous system, sciatic nerve 
injury has been shown to result in increases in PN-1 mes- 
sage RNA [15]. Although tissue culture studies suggest 
that astrocytes are potentially major producers of PN-1 
in the CNS, the cell type responsible for PN-1 produc- 
tion in the peripheral nervous system (PNS) has not pre- 
viously been clearly identified. Schwann cells share many 
properties with astrocytes and are candidates for this 
role. The present report describes the immunocytoche- 
mical, biochemical and functional demonstration of 
PN-1 in cultured Schwann cells. 
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Sciatic nerve Schwann cells were prepared and puri- 
fied according to the method described by Brockes et al. 
[3]. Briefly, sciatic nerves were dissected from neonatal 
Sprague-Dawley rats (Charles River, Wilmington, MA), 
dissociated with 0.1% collagenase and 0.25 % trypsin in 
L-5 medium and plated overnight on poly-L-lysine in 
Dulbecco's modified Eagle's medium (DMEM) contain- 
ing 10 % fetal calf serum (Gibco, Grand Island, NY) and 
10 -5 M cytosine arabinoside. After 48-72 h, the cells 
were trypsinized and suspended in mouse anti-Thy 1.1 
(TIB 103, American Type Culture Collection, Rockville, 
MD) followed by rabbit complement (Pel-Freeze, 
Rogers, AR) to lyse the fibroblasts. Following this, 
Schwann cells were plated in 35 mm tissue culture plates 
coated with poly-L-lysine and grown in medium contain- 
ing 2 x 10 6 forskolin and bovine pituitary extract as de- 
scribed by Porter et al. [17]. After one week in culture, 
immunostaining was done with anti-Thy 1.1 and fluores- 
cein-conjugated goat anti-mouse immunoglobulin 
(Sigma, St. Louis, MO) to confirm removal of fibrob- 
lasts. If positive cells were observed, the complement 
lysis was repeated. Cells were passaged once they 
reached confluence and after about three months in cul- 
ture, they began to show signs of becoming autocrine, as 
described by Porter et al. [17] for Schwann cells grown 
under similar conditions. As in that previous study, cells 
that became mitogen-independent displayed a range of 
morphologies from broad and flat to typical early pas- 
sage Schwann cells. The cultures remained Thy 1.1 nega- 
tive throughout these experiments. To prepare condi- 
tioned media the cultures were placed in serum-free 
medium containing 1 mg/ml BSA for 48h. This was 
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done to prevent complex formation between PN-1 and 
proteases in the FCS. After removal from the cells the 
medium was concentrated 5-fold using Centricon filters 
(Amicon, Danvers, MA) and assayed for thrombin inhi- 
bitory activity in a Chromozym-TH (Boehringer Mann° 
heim, Indianapolis, IN) calorimetric assay [2]. Preincu- 
bation of the conditioned medium with anti-PN-1 anti- 
body was used to test whether the thrombin inhibition 
was due to PN-1. A polyclonal rabbit anti-PN-1 anti- 
body [19] was used in all experiments. For the immuno- 
histochemistry and the Western blotting, a protein A 
fraction was prepared from the anti-PN I serum using an 
Affi-Gel Protein A MAPS kit (Biorad, Riverside, CA). 
PN-1 was purified from C6 glioma conditioned medium 
by the method of Scott et al. [22] and conjugated to CN 
Br Sepharose 4B (Pharmacia, Piscataway, N J) according 
to the manufacturer's instructions. The PN-1-Sepharose 
was then used to affinity-purify the protein A fraction. 
The protein A fraction remaining after removal of the 
Sepharose beads was used as an anti-PN-1 antibody- 
depleted control. Affinity purified anti-PN-1 reacted 
positively with purified PN-1 in a Western blot system, 
while the anti-PN-1 depleted control was negative. 
To test for PN-1 activity in Schwann cell conditioned 
medium, the cells were cultured in serum-free medium 
without growth factors for 24-48 h. The medium was 
then harvested and concentrated ten-fold in a Centricon 
system (Amicon). The concentrated medium was then 
electrophoresed on a 10% polyacrylamide gel [14] and 
electroblotted onto nitrocellulose [23]. The nitrocellulose 
was then cut into strips which were immunostained with 
the rabbit anti-PN I (or with the anti-PN-l-depleted 
antiserum) and developed by incubation with alkaline 
phosphatase conjugated anti-rabbit IgG (Promega, 
Madison, WI). Immuno-cytochemical testing of the cul- 
tures for PN-1 activity was done by standard procedures 
[4] on cells seeded at 1-2 x 10-5/well on poly-L-lysine- 
coated glass cover slips in 12 well plates. 
Fig. 1. PN-1 immunofluorescent staining in Schwann cell cultures. A: phase contrast microscopy of primary Schwann cells, x 400. B: rhodamine 
fluorescence microscopy of the same field as A. Cells were grown and immunostained with anti-PN-l antibody as described in the text. Punctate 
staining of Schwann cell membranes can be seen, C: phase contrast microscopy of autocrine Schwann cells, x 400. Note the flattened morphology. 
D: rhodamine fluorescence microscopy of the same field immunostained with anti-PN-1 antibody and fluorescent second antibody. Note dense posi- 
tive staining on extracellular matrix. Neither normal rabbit serum nor anti-PN-1 antibody-depleted serum produced any staining in any of these 
cultures. 
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In initial studies, Schwann cell cultures were immu- 
nostained with the anti-PN-I antibody and a rhoda- 
mine-conjugated second antibody to assay for the pres- 
ence of PN-1. Primary cells showed a typical Schwann 
cell morphology under phase microscopy (Fig. 1A) and 
expressed faint traces of positive staining for PN-1 in 
either the presence or absence of growth factors (Fig. 
1B). In contrast, autocrine Schwann cells showed a flat- 
tened morphology (Fig. 1C) and appeared to produce 
considerable quantities of PN-I [10]. The pattern was 
suggestive of extracellular matrix staining and appeared 
strongest in those parts of the dish not occupied by 
Schwann cells. Some punctate staining of cell mem- 
branes was also observed. A similar pattern was seen 
with affinity purified anti-PN-1. There was no staining 
above background in either the primary or the autocrine 
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Fig. 2. Western blot of  Schwann cell conditioned media. Conditioned 
media from autocrine Schwann cells was concentrated 10-fold and 
resolved on a 10~ SDS-polyacrylamide gel. The gel was elec~rophore- 
tically blotted onto nitrocellulose paper and stained. A: purified PN-1 
standard; staining with anti-PN-1 antibody demonstrates the typical 
PN-1 band at 43 kDa and a PN-1 dimer at 92 kDa. B: conditioned 
medium; staining with the anti-PN-1 antibody shows a band (arrow) 
that co-migrates with the PN-1 standard at 43 kDa. C: conditioned 
medium; staining with anti-PN-1 antibody-depleted antiserum shows 
loss of  the band at 43 kDa suggesting that the Western blot is demon- 
strating PN- 1 in the conditioned medium. 
ration was used. Although the autocrine cells are not de- 
pendent on exogenous growth factors for proliferation 
in vitro, some autocrine cells were also cultured with 
growth factors. This treatment led to a clear reduction 
of PN-1 immunostaining when compared to cultures 
maintained without growth factors. 
Based on the results from the immunocytochemical 
studies, autocrine cells grown in the absence of growth 
factors were selected as the best source of the immunor- 
eactive PN-l-like material and were therefore used to 
condition medium for biochemical and functional assays 
for PN-1. Conditioned medium was electrophoresed on 
SDS-PAGE, electroblotted to nitrocellulose and immu- 
nostained with anti-PN-1 antibody (Fig. 2). The immu- 
nostaining revealed a protein from the conditioned 
medium that migrated close to the position of the puri- 
fied PN-1 standard. Immunostaining with control anti- 
body preparations was negative. 
To assay for the presence of PN-l-like protease inhibi- 
tory activity the conditioned medium was tested in a 
Chromozym-TH assay. Pre-incubation of thrombin with 
the conditioned medium led to a 23% inhibition of 
thrombin activity in the assay as shown in the graph 
from a typical experiment (Fig. 3). This inhibition was 
prevented by preincubation of the conditioned medium 
with anti-PN-1 antibody. 
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Fig, 3. Antibody inhibition of  protease inhibitory activity in Schwann 
cell conditioned medium. Conditioned medium (CM) was harvested 
from autocrine Schwann cells grown in transparent media for 48 h. It 
was concentrated approximately 5-fold and introduced into a throm- 
bin-Chromozym-TH assay in which it demonstrated thrombin inhibi- 
tory activity. In order to determine whether this activity was due to 
PN-1, a sample of  CM was pre-incubated with anti-PN-1 antiserum 
before incubation with thrombin and Chromozym-TH. The anti-PN-l 
antiserum inhibited the protease inhibitory activity in the CM as was 
demonstrated by a complete reversal of  the thrombin inhibition. 
cal and functional data that support the premise that 
cultured autocrine Schwann cells produce PN- 1 or a very 
closely related molecule. Schwann cell cultures had 
positive immunostaining for PN-1. Western blots of con- 
ditioned medium showed a band that co-migrated with a 
PN-1 standard. A functional assay for thrombin inhibi- 
tion showed inhibition that could itself be inhibited by 
anti-PN-1 antibody. 
PN-1 is the best studied of the nexin family of serine 
protease inhibitors and has been shown to be identical 
to the glial-derived neurite promoting factor [5, 11]. 
Although PN-1 production has been demonstrated in 
astrocytes [18], it has not previously been reported in 
Schwann cells. Schwann cells interact with neurons both 
during normal development and in response to nerve 
injury. Presumably, neuron-glia signalling modulates 
both glial mitogenesis and glial production of neurite 
promoting/trophic factors. Although Howard has 
reported that in fibroblast cultures PN-1 secretion is con- 
stitutive [8], PN-1 secretion has not been fully character- 
ized either in astrocytes or in Schwann cells. Growth in 
culture, in the absence of neurons (or the target cells for 
fibroblast PN I), probably represents an abnormal sys- 
tem lacking in controls and resulting in constitutive pro- 
duction. It is of note that PN-1 production in the 
Schwann cells appeared to be greatest in the autocrine 
cells. Porter et al. have described these cells as retaining 
cell surface markers and the ability to ensheathe axons, 
but also having the ability to proliferate in the absence 
of growth factors or mitogens [17]. It has been suggested 
that they have lost the ability to regulate their own res- 
ponse to the autocrine factor that they secrete. These 
cells also make more autocrine factor than do primary 
Schwann cells. The high levels of PN-I production in 
these cells may be analogous to their high levels of autoc- 
rine factor production. The suppression of autocrine cell 
production of PN-I by addition of growth factors may 
represent restoration of a modulating signal. 
In fibroblast culture PN-1 is secreted and much of it 
becomes bound to the extracellular matrix [4]. Schwann 
cells also produce extracellular matrix and the staining 
pattern seen in the Schwann cell cultures suggests that 
a similar process is going on in these cultures. It is 
reported that matrix binding in fibroblast cultures 
changes the affinity of PN-1 for substrate proteases [25]. 
Although the exact mechanism(s) through which PN- 1 
exerts its effects on neurons has yet to be definitively 
demonstrated, it is of note that the enzymes inhibited by 
PN-1 are important in neuronal migration [24], neurite 
extension [6, 13], nerve muscle synapse formation and 
response to injury [7], neuron ensheathment by Schwann 
cells [9] and modification of the neurotrophic factor fl- 
nerve growth factor [12, 20]. As Schwann cells are 
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involved in many of these processes, it is perhaps not 
surprising to find that Schwann cells make PN-1. There 
is a growing body of knowledge on neuronal and glial 
proteolytic activity in both the central and peripheral 
nervous systems [26]. It has been suggested that a crucial 
balance between proteolytic and protease inhibitory ac- 
tivity is a sine qua non for both normal neuronal devel- 
opment and for neuronal response to injury. Further 
studies are needed to elucidate the role of Schwann cell 
PN-1 both in normal development and in the response 
to nerve injury. 
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